Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategy
{{output}}
Immunotherapy remains an important tool for treatment of hematologic malignancies. The Programmed Death-1 (PD-1) immune checkpoint pathway has emerged as a mechanism of tumor evasion from the anti-tumor immune response. The recent development of anti-PD-1 mono... ...
